Patents Assigned to AnMax, Inc.
  • Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
    Patent number: 6180666
    Abstract: A method is disclosed for increasing bioavailability of an orally administered pharmaceutical compound comprising orally coadministering the pharmaceutical compound to a mammal in need of treatment with the compound and a gallic acid ester. Preferred gallic acid esters of the invention include octyl gallate, propyl gallate, lauryl gallate, and methyl gallate. Improved formulations of pharmaceutical compounds include the gallic acid ester to enhance the bioavailability of the active ingredient of the pharmaceutical compound.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: January 30, 2001
    Assignee: AnMax, Inc.
    Inventors: Vincent J. Wacher, Leslie Z. Benet